微病毒性包容性疾病:一种极其罕见的疾病与一种新的治疗方法
Alexandra Fiedler1, Kevin Brittan1, Wuttiporn Manatsathit2
1Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE.
ACG case reports journal
|October 15, 2024
概括
微病毒性包容性疾病 (MVID) 可以模仿渐进性家族性肝内胆固醇症 (PFIC). 在MVID患者中发现了UNC45A中的新型化合物异构突变,Odevixibat有效地控制了胆固醇性.
科学领域:
- 遗传学 是一个遗传学.
- 胃肠病学 胃肠病学
- 儿科肝病学 儿科肝病学
背景情况:
- 先天性腹,听力损失和胆固醇综合征是罕见的,并且经常被错误诊断.
- 微病毒性包容性疾病 (MVID) 是一种不常见的先天性腹的原因.
- 最近,UNC45A基因突变与MVID有关.
研究的目的:
- 报告一个最初被诊断为PFIC1型的MVID病例.
- 在长期诊断为PFIC的患者中确定MVID的遗传基础.
- 评估Odevixibat在MVID中治疗胆固醇性的疗效.
主要方法:
- 疑似PFIC患者的临床诊断和管理.
- 全基因组测序以确定遗传突变.
- 小肠活检以确认MVID.
主要成果:
- 一名20岁的女性有PFIC1型诊断史,发现她在UNC45A.中具有新型化合物异构基因突变.
- 小肠活检证实了与MVID相一致的小肠缩.
- 奥德维克西巴特治疗导致症状改善和胆固醇性的实验室正常化.
结论:
- UNC45A突变是MVID的一个新发现的原因.
- 在先天性腹和胆固醇综合征的差异诊断中应考虑MVID.
- 奥德维克西巴特在MVID中有效控制胆固醇性,类似于其在PFIC和阿拉吉尔综合征中的有效性.
相关概念视频
01:29Inflammatory Bowel Disease IV: Pharmacological Management
118
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
118
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
143
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
143
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
323
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
323
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
117
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
117
01:27Tumor Immunotherapy
488
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
488